{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:00:18Z","timestamp":1792159218812,"version":"4.4.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["15\/0005364"],"award-info":[{"award-number":["15\/0005364"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/P010695\/1"],"award-info":[{"award-number":["MR\/P010695\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Child Diabetes Foundation"},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"crossref","award":["Thyroid and Virus Detection and Intervention"],"award-info":[{"award-number":["Thyroid and Virus Detection and Intervention"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008871","name":"JDRF","doi-asserted-by":"publisher","award":["5-CDA-2014-221-A-N"],"award-info":[{"award-number":["5-CDA-2014-221-A-N"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union\u2019s Seventh Framework Programme","award":["261441 PEVNET"],"award-info":[{"award-number":["261441 PEVNET"]}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00125-019-4811-7","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T12:56:21Z","timestamp":1554468981000},"page":"744-753","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes"],"prefix":"10.1007","volume":"62","author":[{"given":"Jessica L.","family":"Dunne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Dahl-J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Flodstr\u00f6m-Tullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Hy\u00f6ty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Insel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5ke","family":"Lernmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel G.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"key":"4811_CR1","first-page":"1975","volume":"41","author":"E Gundersen","year":"1927","unstructured":"Gundersen E (1927) Is diabetes of infectious origin? J Infect Dis 41:1975\u20131979","journal-title":"J Infect Dis"},{"issue":"10","key":"4811_CR2","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.autrev.2016.07.019","volume":"15","author":"T Rodriguez-Calvo","year":"2016","unstructured":"Rodriguez-Calvo T, Sabouri S, Anquetil F, von Herrath MG (2016) The viral paradigm in type 1 diabetes: who are the main suspects? Autoimmun Rev 15(10):964\u2013969. \n                    https:\/\/doi.org\/10.1016\/j.autrev.2016.07.019","journal-title":"Autoimmun Rev"},{"issue":"5671","key":"4811_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/bmj.3.5671.631","volume":"3","author":"DR Gamble","year":"1969","unstructured":"Gamble DR, Taylor KW (1969) Seasonal incidence of diabetes mellitus. Br Med J 3(5671):631\u2013633. \n                    https:\/\/doi.org\/10.1136\/bmj.3.5671.631","journal-title":"Br Med J"},{"issue":"5887","key":"4811_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/bmj.4.5887.260","volume":"4","author":"DR Gamble","year":"1973","unstructured":"Gamble DR, Taylor KW, Cumming H (1973) Coxsackie viruses and diabetes mellitus. Br Med J 4(5887):260\u2013262. \n                    https:\/\/doi.org\/10.1136\/bmj.4.5887.260","journal-title":"Br Med J"},{"issue":"8","key":"4811_CR5","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s00125-013-2924-y","volume":"56","author":"HS Lee","year":"2013","unstructured":"Lee HS, Briese T, Winkler C et al (2013) Next-generation sequencing for viruses in children with rapid-onset type 1 diabetes. Diabetologia 56(8):1705\u20131711. \n                    https:\/\/doi.org\/10.1007\/s00125-013-2924-y","journal-title":"Diabetologia"},{"issue":"12","key":"4811_CR6","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.2337\/db10-0866","volume":"59","author":"LC Stene","year":"2010","unstructured":"Stene LC, Oikarinen S, Hyoty H et al (2010) Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes 59(12):3174\u20133180. \n                    https:\/\/doi.org\/10.2337\/db10-0866","journal-title":"Diabetes"},{"issue":"1","key":"4811_CR7","doi-asserted-by":"publisher","first-page":"32899","DOI":"10.1038\/srep32899","volume":"6","author":"MP Ashton","year":"2016","unstructured":"Ashton MP, Eugster A, Walther D et al (2016) Incomplete immune response to coxsackie B viruses associates with early autoimmunity against insulin. Sci Rep 6(1):32899. \n                    https:\/\/doi.org\/10.1038\/srep32899","journal-title":"Sci Rep"},{"issue":"1","key":"4811_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/jmv.10260","volume":"69","author":"K Salminen","year":"2003","unstructured":"Salminen K, Sadeharju K, Lonnrot M et al (2003) Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J Med Virol 69(1):91\u201398. \n                    https:\/\/doi.org\/10.1002\/jmv.10260","journal-title":"J Med Virol"},{"issue":"Suppl 22","key":"4811_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/pedi.12370","volume":"17","author":"H Hyoty","year":"2016","unstructured":"Hyoty H (2016) Viruses in type 1 diabetes. Pediatr Diabetes 17(Suppl 22):56\u201364. \n                    https:\/\/doi.org\/10.1111\/pedi.12370","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"4811_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00125-014-3400-z","volume":"58","author":"HC Lin","year":"2015","unstructured":"Lin HC, Wang CH, Tsai FJ et al (2015) Enterovirus infection is associated with an increased risk of childhood type 1 diabetes in Taiwan: a nationwide population-based cohort study. Diabetologia 58(1):79\u201386. \n                    https:\/\/doi.org\/10.1007\/s00125-014-3400-z","journal-title":"Diabetologia"},{"issue":"3","key":"4811_CR11","doi-asserted-by":"publisher","first-page":"e1974","DOI":"10.1002\/rmv.1974","volume":"28","author":"DW Allen","year":"2018","unstructured":"Allen DW, Kim KW, Rawlinson WD, Craig ME (2018) Maternal virus infections in pregnancy and type 1 diabetes in their offspring: systematic review and meta-analysis of observational studies. Rev Med Virol 28(3):e1974. \n                    https:\/\/doi.org\/10.1002\/rmv.1974","journal-title":"Rev Med Virol"},{"issue":"3","key":"4811_CR12","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s00125-016-4177-z","volume":"60","author":"H Honkanen","year":"2017","unstructured":"Honkanen H, Oikarinen S, Nurminen N et al (2017) Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity. Diabetologia 60(3):424\u2013431. \n                    https:\/\/doi.org\/10.1007\/s00125-016-4177-z","journal-title":"Diabetologia"},{"issue":"2","key":"4811_CR13","doi-asserted-by":"publisher","first-page":"446","DOI":"10.2337\/db13-0619","volume":"63","author":"OH Laitinen","year":"2014","unstructured":"Laitinen OH, Honkanen H, Pakkanen O et al (2014) Coxsackievirus B1 is associated with induction of \u03b2-cell autoimmunity that portends type 1 diabetes. Diabetes 63(2):446\u2013455. \n                    https:\/\/doi.org\/10.2337\/db13-0619","journal-title":"Diabetes"},{"issue":"6","key":"4811_CR14","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/ng1800","volume":"38","author":"Deborah J Smyth","year":"2006","unstructured":"Smyth DJ, Cooper JD, Bailey R et al (2006) A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 38:617\u2013619","journal-title":"Nature Genetics"},{"issue":"1","key":"4811_CR15","doi-asserted-by":"publisher","first-page":"39378","DOI":"10.1038\/srep39378","volume":"6","author":"E Domsgen","year":"2016","unstructured":"Domsgen E, Lind K, Kong L et al (2016) An IFIH1 gene polymorphism associated with risk for autoimmunity regulates canonical antiviral defence pathways in Coxsackievirus infected human pancreatic islets. Sci Rep 6(1):39378. \n                    https:\/\/doi.org\/10.1038\/srep39378","journal-title":"Sci Rep"},{"issue":"11","key":"4811_CR16","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1007\/s00125-016-4067-4","volume":"59","author":"SJ Richardson","year":"2016","unstructured":"Richardson SJ, Rodriguez-Calvo T, Gerling IC et al (2016) Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes. Diabetologia 59(11):2448\u20132458. \n                    https:\/\/doi.org\/10.1007\/s00125-016-4067-4","journal-title":"Diabetologia"},{"issue":"11","key":"4811_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11892-015-0656-8","volume":"15","author":"BM Looney","year":"2015","unstructured":"Looney BM, Xia CQ, Concannon P, Ostrov DA, Clare-Salzler MJ (2015) Effects of type 1 diabetes-associated IFIH1 polymorphisms on MDA5 function and expression. Curr Diab Rep 15(11):96. \n                    https:\/\/doi.org\/10.1007\/s11892-015-0656-8","journal-title":"Curr Diab Rep"},{"issue":"1","key":"4811_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/hmg\/ddp474","volume":"19","author":"ML Colli","year":"2010","unstructured":"Colli ML, Moore F, Gurzov EN, Ortis F, Eizirik DL (2010) MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic beta-cell responses to the viral by-product double-stranded RNA. Hum Mol Genet 19(1):135\u2013146. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddp474","journal-title":"Hum Mol Genet"},{"issue":"4","key":"4811_CR19","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s00125-016-4201-3","volume":"60","author":"L Marroqui","year":"2017","unstructured":"Marroqui L, Dos Santos RS, Op de Beeck A et al (2017) Interferon-alpha mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes. Diabetologia 60(4):656\u2013667. \n                    https:\/\/doi.org\/10.1007\/s00125-016-4201-3","journal-title":"Diabetologia"},{"issue":"21","key":"4811_CR20","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJM197905243002102","volume":"300","author":"JW Yoon","year":"1979","unstructured":"Yoon JW, Austin M, Onodera T, Notkins AL (1979) Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 300(21):1173\u20131179. \n                    https:\/\/doi.org\/10.1056\/NEJM197905243002102","journal-title":"N Engl J Med"},{"issue":"12","key":"4811_CR21","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1073\/pnas.0700442104","volume":"104","author":"F Dotta","year":"2007","unstructured":"Dotta F, Censini S, van Halteren AG et al (2007) Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A 104(12):5115\u20135120. \n                    https:\/\/doi.org\/10.1073\/pnas.0700442104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"4811_CR22","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/dmrr.1237","volume":"27","author":"T Kobayashi","year":"2011","unstructured":"Kobayashi T, Nishida Y, Tanaka S, Aida K (2011) Pathological changes in the pancreas of fulminant type 1 diabetes and slowly progressive insulin-dependent diabetes mellitus (SPIDDM): innate immunity in fulminant type 1 diabetes and SPIDDM. Diabetes Metab Res Rev 27(8):965\u2013970. \n                    https:\/\/doi.org\/10.1002\/dmrr.1237","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"4811_CR23","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00125-009-1276-0","volume":"52","author":"SJ Richardson","year":"2009","unstructured":"Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG (2009) The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 52(6):1143\u20131151. \n                    https:\/\/doi.org\/10.1007\/s00125-009-1276-0","journal-title":"Diabetologia"},{"issue":"1","key":"4811_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00125-012-2745-4","volume":"56","author":"SJ Richardson","year":"2013","unstructured":"Richardson SJ, Leete P, Bone AJ, Foulis AK, Morgan NG (2013) Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1. Diabetologia 56(1):185\u2013193. \n                    https:\/\/doi.org\/10.1007\/s00125-012-2745-4","journal-title":"Diabetologia"},{"issue":"5","key":"4811_CR25","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.2337\/db14-1370","volume":"64","author":"L Krogvold","year":"2015","unstructured":"Krogvold L, Edwin B, Buanes T et al (2015) Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes 64(5):1682\u20131687. \n                    https:\/\/doi.org\/10.2337\/db14-1370","journal-title":"Diabetes"},{"issue":"4","key":"4811_CR26","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00125-013-3155-y","volume":"57","author":"L Krogvold","year":"2014","unstructured":"Krogvold L, Edwin B, Buanes T et al (2014) Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study. Diabetologia 57(4):841\u2013843. \n                    https:\/\/doi.org\/10.1007\/s00125-013-3155-y","journal-title":"Diabetologia"},{"key":"4811_CR27","first-page":"S167","volume":"60","author":"L Krogvold","year":"2017","unstructured":"Krogvold L, Genoni A, Puggioni A et al (2017) Enterovirus in the pancreas of live adult patients with newly diagnosed type 1 diabetes. Results from the DiViD study. Diabetologia 60:S167 (Abstract)","journal-title":"Diabetologia"},{"issue":"2","key":"4811_CR28","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00125-013-3094-7","volume":"57","author":"SJ Richardson","year":"2014","unstructured":"Richardson SJ, Leete P, Dhayal S et al (2014) Evaluation of the fidelity of immunolabelling obtained with clone 5D8\/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas. Diabetologia 57(2):392\u2013401. \n                    https:\/\/doi.org\/10.1007\/s00125-013-3094-7","journal-title":"Diabetologia"},{"issue":"12","key":"4811_CR29","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.tem.2014.08.002","volume":"25","author":"NG Morgan","year":"2014","unstructured":"Morgan NG, Richardson SJ (2014) Enteroviruses as causative agents in type 1 diabetes: loose ends or lost cause? Trends Endocrinol Metab 25(12):611\u2013619. \n                    https:\/\/doi.org\/10.1016\/j.tem.2014.08.002","journal-title":"Trends Endocrinol Metab"},{"key":"4811_CR30","first-page":"275","volume":"323","author":"NM Chapman","year":"2008","unstructured":"Chapman NM, Kim KS (2008) Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr Top Microbiol Immunol 323:275\u2013292","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"4811_CR31","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/jmv.24039","volume":"87","author":"S Tracy","year":"2015","unstructured":"Tracy S, Smithee S, Alhazmi A, Chapman N (2015) Coxsackievirus can persist in murine pancreas by deletion of 5\u2032 terminal genomic sequences. J Med Virol 87(2):240\u2013247. \n                    https:\/\/doi.org\/10.1002\/jmv.24039","journal-title":"J Med Virol"},{"issue":"11","key":"4811_CR32","doi-asserted-by":"publisher","first-page":"7024","DOI":"10.1128\/JVI.79.11.7024-7041.2005","volume":"79","author":"K.-S. Kim","year":"2005","unstructured":"Kim KS, Tracy S, Tapprich W et al (2005) 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. J Virol 79(11):7024\u20137041. \n                    https:\/\/doi.org\/10.1128\/JVI.79.11.7024-7041.2005","journal-title":"Journal of Virology"},{"issue":"1","key":"4811_CR33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.virusres.2005.10.016","volume":"119","author":"RE Lloyd","year":"2006","unstructured":"Lloyd RE (2006) Translational control by viral proteinases. Virus Res 119(1):76\u201388. \n                    https:\/\/doi.org\/10.1016\/j.virusres.2005.10.016","journal-title":"Virus Res"},{"issue":"9","key":"4811_CR34","doi-asserted-by":"publisher","first-page":"e1002267","DOI":"10.1371\/journal.ppat.1002267","volume":"7","author":"ML Colli","year":"2011","unstructured":"Colli ML, Nogueira TC, Allagnat F et al (2011) Exposure to the viral by-product dsRNA or Coxsackievirus B5 triggers pancreatic beta cell apoptosis via a Bim \/ Mcl-1 imbalance. PLoS Pathog 7(9):e1002267. \n                    https:\/\/doi.org\/10.1371\/journal.ppat.1002267","journal-title":"PLoS Pathog"},{"issue":"11","key":"4811_CR35","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1007\/s00125-018-4704-1","volume":"61","author":"E Ifie","year":"2018","unstructured":"Ifie E, Russell MA, Dhayal S et al (2018) Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells. Diabetologia 61(11):2344\u20132355. \n                    https:\/\/doi.org\/10.1007\/s00125-018-4704-1","journal-title":"Diabetologia"},{"issue":"5","key":"4811_CR36","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00125-018-4561-y","volume":"61","author":"AB Sioofy-Khojine","year":"2018","unstructured":"Sioofy-Khojine AB, Lehtonen J, Nurminen N et al (2018) Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes. Diabetologia 61(5):1193\u20131202. \n                    https:\/\/doi.org\/10.1007\/s00125-018-4561-y","journal-title":"Diabetologia"},{"issue":"6","key":"4811_CR37","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1080\/21505594.2016.1252018","volume":"8","author":"F Elmastour","year":"2017","unstructured":"Elmastour F, Jaidane H, Benkahla M et al (2017) Anti-coxsackievirus B4 (CV-B4) enhancing activity of serum associated with increased viral load and pathology in mice reinfected with CV-B4. Virulence 8(6):908\u2013923. \n                    https:\/\/doi.org\/10.1080\/21505594.2016.1252018","journal-title":"Virulence"},{"issue":"6053","key":"4811_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1126\/science.1211057","volume":"334","author":"SK Kuss","year":"2011","unstructured":"Kuss SK, Best GT, Etheredge CA et al (2011) Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 334(6053):249\u2013252. \n                    https:\/\/doi.org\/10.1126\/science.1211057","journal-title":"Science"},{"issue":"Suppl 3","key":"4811_CR39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/dom.12166","volume":"15","author":"G Afonso","year":"2013","unstructured":"Afonso G, Mallone R (2013) Infectious triggers in type 1 diabetes: is there a case for epitope mimicry? Diabetes Obes Metab 15(Suppl 3):82\u201388. \n                    https:\/\/doi.org\/10.1111\/dom.12166","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"4811_CR40","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s00125-012-2762-3","volume":"56","author":"DL Eizirik","year":"2013","unstructured":"Eizirik DL, Miani M, Cardozo AK (2013) Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia 56(2):234\u2013241. \n                    https:\/\/doi.org\/10.1007\/s00125-012-2762-3","journal-title":"Diabetologia"},{"key":"4811_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fcell.2015.00067","volume":"3","author":"ML Marre","year":"2015","unstructured":"Marre ML, James EA, Piganelli JD (2015) \u03b2 Cell ER stress and the implications for immunogenicity in type 1 diabetes. Front Cell Dev Biol 3:67","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"4811_CR42","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.2337\/db16-0180","volume":"65","author":"EA Phelps","year":"2016","unstructured":"Phelps EA, Cianciaruso C, Michael IP et al (2016) Aberrant accumulation of the diabetes autoantigen GAD65 in Golgi membranes in conditions of ER stress and autoimmunity. Diabetes 65(9):2686\u20132699. \n                    https:\/\/doi.org\/10.2337\/db16-0180","journal-title":"Diabetes"},{"issue":"2","key":"4811_CR43","doi-asserted-by":"publisher","first-page":"460","DOI":"10.2337\/db16-0671","volume":"66","author":"C Cianciaruso","year":"2017","unstructured":"Cianciaruso C, Phelps EA, Pasquier M et al (2017) Primary human and rat \u03b2-cells release the intracellular autoantigens GAD65, IA-2, and proinsulin in exosomes together with cytokine-induced enhancers of immunity. Diabetes 66(2):460\u2013473. \n                    https:\/\/doi.org\/10.2337\/db16-0671","journal-title":"Diabetes"},{"issue":"5","key":"4811_CR44","doi-asserted-by":"publisher","first-page":"708","DOI":"10.2337\/diabetes.49.5.708","volume":"49","author":"DV Serreze","year":"2000","unstructured":"Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA (2000) Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 49(5):708\u2013711. \n                    https:\/\/doi.org\/10.2337\/diabetes.49.5.708","journal-title":"Diabetes"},{"issue":"11","key":"4811_CR45","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1128\/JVI.02361-05","volume":"80","author":"T. Kanno","year":"2006","unstructured":"Kanno T, Kim K, Kono K, Drescher KM, Chapman NM, Tracy S (2006) Group B Coxsackievirus diabetogenic phenotype correlates with replication efficiency. J Virol 80(11):5637\u20135643. \n                    https:\/\/doi.org\/10.1128\/JVI.02361-05","journal-title":"Journal of Virology"},{"issue":"2","key":"4811_CR46","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s00125-014-3436-0","volume":"58","author":"PG Larsson","year":"2015","unstructured":"Larsson PG, Lakshmikanth T, Laitinen OH et al (2015) A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models. Diabetologia 58(2):346\u2013354. \n                    https:\/\/doi.org\/10.1007\/s00125-014-3436-0","journal-title":"Diabetologia"},{"issue":"2","key":"4811_CR47","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.clim.2003.09.014","volume":"110","author":"MS Horwitz","year":"2004","unstructured":"Horwitz MS, Ilic A, Fine C, Balasa B, Sarvetnick N (2004) Coxsackieviral-mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells. Clin Immunol 110(2):134\u2013144. \n                    https:\/\/doi.org\/10.1016\/j.clim.2003.09.014","journal-title":"Clin Immunol"},{"issue":"7","key":"4811_CR48","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nm0798-781","volume":"4","author":"Marc S. Horwitz","year":"1998","unstructured":"Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N (1998) Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 4:781\u2013785","journal-title":"Nature Medicine"},{"issue":"8","key":"4811_CR49","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1172\/JCI94549","volume":"127","author":"A Pugliese","year":"2017","unstructured":"Pugliese A (2017) Autoreactive T cells in type 1 diabetes. J Clin Invest 127(8):2881\u20132891. \n                    https:\/\/doi.org\/10.1172\/JCI94549","journal-title":"J Clin Invest"},{"issue":"4","key":"4811_CR50","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.2337\/db14-1020","volume":"64","author":"GR Gallagher","year":"2015","unstructured":"Gallagher GR, Brehm MA, Finberg RW et al (2015) Viral infection of engrafted human islets leads to diabetes. Diabetes 64(4):1358\u20131369. \n                    https:\/\/doi.org\/10.2337\/db14-1020","journal-title":"Diabetes"},{"issue":"6","key":"4811_CR51","doi-asserted-by":"publisher","first-page":"e0199323","DOI":"10.1371\/journal.pone.0199323","volume":"13","author":"R Kundu","year":"2018","unstructured":"Kundu R, Knight R, Dunga M, Peakman M (2018) In silico and ex vivo approaches indicate immune pressure on capsid and non-capsid regions of Coxsackie B viruses in the human system. PLoS One 13(6):e0199323. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0199323","journal-title":"PLoS One"},{"issue":"2","key":"4811_CR52","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00125-017-4492-z","volume":"61","author":"VM Stone","year":"2018","unstructured":"Stone VM, Hankaniemi MM, Svedin E et al (2018) A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes. Diabetologia 61(2):476\u2013481. \n                    https:\/\/doi.org\/10.1007\/s00125-017-4492-z","journal-title":"Diabetologia"},{"issue":"10","key":"4811_CR53","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2337\/dc15-1419","volume":"38","author":"RA Insel","year":"2015","unstructured":"Insel RA, Dunne JL, Atkinson MA et al (2015) Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 38(10):1964\u20131974. \n                    https:\/\/doi.org\/10.2337\/dc15-1419","journal-title":"Diabetes Care"},{"key":"4811_CR54","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.antiviral.2015.01.010","volume":"116","author":"EK Alidjinou","year":"2015","unstructured":"Alidjinou EK, Sane F, Bertin A, Caloone D, Hober D (2015) Persistent infection of human pancreatic cells with Coxsackievirus B4 is cured by fluoxetine. Antivir Res 116:51\u201354. \n                    https:\/\/doi.org\/10.1016\/j.antiviral.2015.01.010","journal-title":"Antivir Res"},{"issue":"12","key":"4811_CR55","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1080\/17474124.2017.1361822","volume":"11","author":"M Okada","year":"2017","unstructured":"Okada M, Enomoto M, Kawada N, Nguyen MH (2017) Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis. Expert Rev Gastroenterol Hepatol 11(12):1095\u20131104. \n                    https:\/\/doi.org\/10.1080\/17474124.2017.1361822","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"4811_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3851\/IMP2975","volume":"21","author":"V Soriano","year":"2016","unstructured":"Soriano V, Labarga P, Fernandez-Montero JV et al (2016) Hepatitis C cure with antiviral therapy--benefits beyond the liver. Antivir Ther 21(1):1\u20138. \n                    https:\/\/doi.org\/10.3851\/IMP2975","journal-title":"Antivir Ther"},{"key":"4811_CR57","doi-asserted-by":"publisher","first-page":"e2916","DOI":"10.1002\/dmrr.2916","volume":"33","author":"F Badia-Boungou","year":"2017","unstructured":"Badia-Boungou F, Sane F, Alidjinou EK et al (2017) Marker of coxsackievirus-B4 infection in saliva of patients with type 1 diabetes. Diabetes Metab Res Rev 33:e2916","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"4811_CR58","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/jmv.23476","volume":"85","author":"SS Hammerstad","year":"2013","unstructured":"Hammerstad SS, Tauriainen S, Hyoty H, Paulsen T, Norheim I, Dahl-Jorgensen K (2013) Detection of enterovirus in the thyroid tissue of patients with graves\u2019 disease. J Med Virol 85(3):512\u2013518. \n                    https:\/\/doi.org\/10.1002\/jmv.23476","journal-title":"J Med Virol"},{"issue":"3","key":"4811_CR59","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1089\/thy.2012.0264","volume":"23","author":"SS Hammerstad","year":"2013","unstructured":"Hammerstad SS, Jahnsen FL, Tauriainen S, Hy\u00f6ty H, Paulsen T, Norheim I, Dahl-J\u00f8rgensen K (2013) Inflammation and increased myxovirus resistance protein A expression in thyroid tissue in the early stages of Hashimoto\u2019s thyroiditis. Thyroid 23(3):334\u2013341. \n                    https:\/\/doi.org\/10.1089\/thy.2012.0264","journal-title":"Thyroid"},{"key":"4811_CR60","doi-asserted-by":"publisher","unstructured":"Nederstigt C, Uitbeijerse B, Janssen L, Corssmit EP, de Koning E, Dekkers O (2018) Associated auto-immune disease in type 1 diabetes patients: a systematic review and meta-analysis. Eur J Endocrinol:137\u2013146. \n                    https:\/\/doi.org\/10.1530\/EJE-18-0515","DOI":"10.1530\/EJE-18-0515"},{"issue":"3","key":"4811_CR61","doi-asserted-by":"publisher","first-page":"687","DOI":"10.2337\/db11-1157","volume":"61","author":"M Oikarinen","year":"2012","unstructured":"Oikarinen M, Tauriainen S, Oikarinen S et al (2012) Type 1 diabetes is associated with enterovirus infection in gut mucosa. Diabetes 61(3):687\u2013691. \n                    https:\/\/doi.org\/10.2337\/db11-1157","journal-title":"Diabetes"},{"key":"4811_CR62","unstructured":"Proventionbio (2017) Provention Bio, Inc. Announces clinical program focus on intercepting and preventing the onset of type 1 diabetes. Available from \n                    http:\/\/investors.proventionbio.com\/2017-07-18-Provention-Bio-Inc-Announces-Clinical-Program-Focused-on-Intercepting-and-Preventing-the-Onset-of-Type-1-Diabetes\n                    \n                  . Accessed 18 December 2018"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-019-4811-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-019-4811-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-019-4811-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T19:05:26Z","timestamp":1579719926000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-019-4811-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["4811"],"URL":"https:\/\/doi.org\/10.1007\/s00125-019-4811-7","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,23]]},"assertion":[{"value":"21 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HH is a shareholder and member of the Board of Vactech Ltd., which develops picornavirus vaccines. RAI, HH and MF-T serve on the scientific advisory board of Provention Bio Inc., which is developing an enterovirus vaccine. RAI has stock options in Provention Bio Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}}]}}